[HTML][HTML] Targeting apoptotic caspases in cancer
A Boice, L Bouchier-Hayes - … et Biophysica Acta (BBA)-Molecular Cell …, 2020 - Elsevier
Members of the caspase family of proteases play essential roles in the initiation and
execution of apoptosis. These caspases are divided into two groups: the initiator caspases …
execution of apoptosis. These caspases are divided into two groups: the initiator caspases …
Cellular responses to Cisplatin‐induced DNA damage
A Basu, S Krishnamurthy - Journal of nucleic acids, 2010 - Wiley Online Library
Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid
tumors. It is generally considered as a cytotoxic drug which kills cancer cells by damaging …
tumors. It is generally considered as a cytotoxic drug which kills cancer cells by damaging …
Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models
L Su, Y Chen, C Huang, S Wu, XJ Wang… - Science translational …, 2023 - science.org
Pancreatic and lung cancers frequently develop resistance to chemotherapy-induced cell
apoptosis during the treatment, indicating that targeting nonapoptotic-related pathways …
apoptosis during the treatment, indicating that targeting nonapoptotic-related pathways …
Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy
Activation of transcription factor NF-κB is frequently encountered in tumor cells and
contributes to aggressive tumor growth and resistance to chemotherapy and ionizing …
contributes to aggressive tumor growth and resistance to chemotherapy and ionizing …
[HTML][HTML] Chemoresistance and targeted therapies in ovarian and endometrial cancers
Gynecological cancers are known for being very aggressive at their advanced stages.
Indeed, the survival rate of both ovarian and endometrial cancers is very low when …
Indeed, the survival rate of both ovarian and endometrial cancers is very low when …
Oncogenic EGFR signaling activates an mTORC2–NF-κB pathway that promotes chemotherapy resistance
Although it is known that mTOR complex 2 (mTORC2) functions upstream of Akt, the role of
this protein kinase complex in cancer is not well understood. Through an integrated analysis …
this protein kinase complex in cancer is not well understood. Through an integrated analysis …
FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP
Y Tsuchiya, O Nakabayashi, H Nakano - International journal of molecular …, 2015 - mdpi.com
cFLIP (cellular FLICE-like inhibitory protein) is structurally related to caspase-8 but lacks
proteolytic activity due to multiple amino acid substitutions of catalytically important residues …
proteolytic activity due to multiple amino acid substitutions of catalytically important residues …
[HTML][HTML] Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4-and HIF-1α-mediated regulation of apoptosis and autophagy
X Zhang, Z Qi, H Yin, G Yang - Theranostics, 2019 - ncbi.nlm.nih.gov
The interplay between p53 and RAS signaling regulates cancer chemoresistance, but the
detailed mechanism is unclear. In this study, we investigated the interactive effects of p53 …
detailed mechanism is unclear. In this study, we investigated the interactive effects of p53 …
The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
M Asare-Werehene, K Nakka, A Reunov, CT Chiu… - Oncogene, 2020 - nature.com
Ovarian cancer (OVCA) is the most lethal gynecological cancer, due predominantly to late
presentation, high recurrence rate and common chemoresistance development. The …
presentation, high recurrence rate and common chemoresistance development. The …
Sequential Ubiquitination and Phosphorylation Epigenetics Reshaping by MG132‐Loaded Fe‐MOF Disarms Treatment Resistance to Repulse Metastatic Colorectal …
Z Bu, J Yang, Y Zhang, T Luo, C Fang… - Advanced …, 2023 - Wiley Online Library
Abnormal epigenetic regulation is identified to correlate with cancer progression and
renders tumor refractory and resistant to reactive oxygen species (ROS)‐based anti‐tumor …
renders tumor refractory and resistant to reactive oxygen species (ROS)‐based anti‐tumor …